These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2827846)

  • 1. MPDP+ causes a non-reversible decrease in neostriatal synaptic transmission in mouse brain slice.
    Wilson JA; Wilson JS; Weight FF
    Brain Res; 1987 Nov; 425(2):376-9. PubMed ID: 2827846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MPTP causes a non-reversible depression of synaptic transmission in mouse neostriatal brain slice.
    Wilson JA; Wilson JS; Weight FF
    Brain Res; 1986 Mar; 368(2):357-60. PubMed ID: 3008929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MPTP, MPDP+ and MPP+ cause decreases in dopamine content in mouse brain slices.
    Wilson JA; Doyle TJ; Lau YS
    Neurosci Lett; 1990 Jan; 108(1-2):213-8. PubMed ID: 2304632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of MPTP and MPP+ on synaptic transmission in guinea-pig hippocampal slices.
    Galvan M; Kupsch A; ten Bruggencate G
    Exp Neurol; 1987 May; 96(2):289-98. PubMed ID: 3032664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of MPTP on synaptic transmission is affected by changes in Ca2+ concentrations.
    Wilson JA; Lau YS; Gleeson JG; Wilson JS
    Brain Res; 1991 Feb; 541(2):342-6. PubMed ID: 1647250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Singer TP; Salach JI; Crabtree D
    Biochem Biophys Res Commun; 1985 Mar; 127(2):707-12. PubMed ID: 3872126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G; Nwanze E; Luthman J; Sundström E
    Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacological manipulations with MPTP.
    Barnes NJ; Bradbury AJ; Costall B; Domeney AM; Kelly ME; Naylor RJ
    J Neural Transm Suppl; 1986; 20():47-63. PubMed ID: 3091761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+.
    Schildknecht S; Pape R; Meiser J; Karreman C; Strittmatter T; Odermatt M; Cirri E; Friemel A; Ringwald M; Pasquarelli N; Ferger B; Brunner T; Marx A; Möller HM; Hiller K; Leist M
    Antioxid Redox Signal; 2015 Nov; 23(13):1001-16. PubMed ID: 26413876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.
    Wu EY; Langston JW; Di Monte DA
    J Pharmacol Exp Ther; 1992 Jul; 262(1):225-30. PubMed ID: 1625201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone.
    Yoshihara S; Ohta S
    Arch Biochem Biophys; 1998 Dec; 360(1):93-8. PubMed ID: 9826433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases.
    Singer TP; Salach JI; Castagnoli N; Trevor A
    Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MPTP-meditated hippocampal dopamine deprivation modulates synaptic transmission and activity-dependent synaptic plasticity.
    Zhu G; Chen Y; Huang Y; Li Q; Behnisch T
    Toxicol Appl Pharmacol; 2011 Aug; 254(3):332-41. PubMed ID: 21605582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA
    Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
    Herraiz T; Arán VJ; Guillén H
    Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
    Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
    Nagatsu T; Hirata Y
    Eur Neurol; 1987; 26 Suppl 1():11-5. PubMed ID: 2884110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.
    Del Zompo M; Piccardi MP; Ruiu S; Quartu M; Gessa GL; Vaccari A
    Br J Pharmacol; 1993 Jun; 109(2):411-4. PubMed ID: 8102929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.